GLP-1 Weight Loss Drugs Linked to Surprising Behavioral Benefits Ozempic and Wegovy May Diminish the Link Between Impulsivity and Violent Behaviour GLP-1 medications prescribed for weight loss or diab...
The End of the 1948 GP Model? Kent’s 100% Sign-Up to Mega-Practice Care Radical NHS Transformation: All 140 GP practices in Kent and Medway have signed up for the £10 million Single Neighbourhood Heal...
Phase 2 BESTOW Data Suggests Tegoprubart is Superior to Tacrolimus in Kidney Transplant Patients A recent clinical trial reveals that an experimental, calcineurin-inhibitor-free immunosuppressant drug...
Louisiana man becomes first in region to be cured of sickle cell disease A young south-eastern Louisiana man recently became the first person in his region to be functionally cured of sickle cell dise...
Recent Australian Study Shows Why Walking Slows with Age New research from Flinders University and the University of Canberra reveals that the aging body gradually sacrifices walking efficiency to pri...
CAR T-Cell Therapy and ‘Immune Reset’: A Potential Revolution in Lupus Treatment On 12th June 2026, the BBC reported on a breakthrough NHS clinical trial led by University College London H...
The FDA has recently approved AstraZeneca’s Baxfendy (baxdrostat), a first-in-class oral medication for adults struggling with uncontrolled high blood pressure. Target Audience: It is designed s...
The FDA has recently expanded approval for Afrezza (insulin human) Inhalation Powder to include children and adolescents aged 6 years and older. This ultra-rapid-acting mealtime insulin is delivered d...
The 500,000 Staff NHS AI Rollout The Announcement: On 8th June 2026, NHS England announced it was accelerating generative AI adoption by rolling out secure digital personal assistants to over 505,000 ...
Introduction On Tuesday, May 26, 2026, President Donald Trump, 79, completed a three-and-a-half-hour medical examination at Walter Reed National Military Medical Center. The White House subsequ...
